These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10831465)

  • 1. First-episode psychosis in a managed care setting: clinical management and research.
    Jarskog LF; Mattioli MA; Perkins DO; Lieberman JA
    Am J Psychiatry; 2000 Jun; 157(6):878-84. PubMed ID: 10831465
    [No Abstract]   [Full Text] [Related]  

  • 2. Managed care considerations. Optimal pharmacotherapy of schizophrenia.
    Muller R
    Manag Care; 2014 Apr; 23(4 Suppl 1):4. PubMed ID: 25029780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].
    Sárosi A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual health outcomes and treatment costs for schizophrenia populations.
    Mauskopf JA; David K; Grainger DL; Gibson PJ
    J Clin Psychiatry; 1999; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients: results from electronic Schizophrenia Treatment Adherence Registry (e-STAR) and Trial for the Initiation and Maintenance Of REmission in Schizophrenia with risperidone (TIMORES).
    Dubois V; Peuskens J; Geerts P; Detraux J
    Early Interv Psychiatry; 2014 Feb; 8(1):39-49. PubMed ID: 23343330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 7. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a managed care perspective.
    Liu J
    Am J Manag Care; 2014 Jun; 20(8 Suppl):S174-83. PubMed ID: 25180707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R
    World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics in the managed care era.
    Loebel AD; Botts SR; Feldman BI
    Am J Manag Care; 1998 Jan; 4 Suppl():S37-50; quiz S51-2. PubMed ID: 10181074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting.
    Ascher-Svanum H; Kennedy JS; Lee D; Haberman M
    Am J Manag Care; 2004 Jan; 10(1):20-4. PubMed ID: 14738183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.
    Emsley R; Oosthuizen PP; Koen L; Niehaus DJ; Martinez G
    J Clin Psychiatry; 2012 Apr; 73(4):e541-7. PubMed ID: 22579160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in first-episode schizophrenia after a 1 year remission.
    Liu S; Yuan YB; Guan LL; Wei H; Cheng Z; Han X; Yang L; Pu CC; Yang FD; Lu Z; Deng H; Zhao JP; Yu X
    Chin Med J (Engl); 2013 Jul; 126(14):2676-80. PubMed ID: 23876895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice.
    Mahmoud R; Engelhart L; Ollendorf D; Oster G
    J Clin Psychiatry; 1999; 60 Suppl 3():42-7; discussion 48. PubMed ID: 10073377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mood stabilizers among patients with schizophrenia, 1994-2001.
    Citrome L; Jaffe A; Levine J; Allingham B
    Psychiatr Serv; 2002 Oct; 53(10):1212. PubMed ID: 12364663
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of treatment response in second-episode versus first-episode schizophrenia.
    Emsley R; Oosthuizen P; Koen L; Niehaus D; Martinez L
    J Clin Psychopharmacol; 2013 Feb; 33(1):80-3. PubMed ID: 23277247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic drug treatment in the prodromal phase of schizophrenia.
    Cannon TD; Huttunen MO; Dahlström M; Larmo I; Räsänen P; Juriloo A
    Am J Psychiatry; 2002 Jul; 159(7):1230-2. PubMed ID: 12091205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.